Eric Venker
CIK 1801917 · President & Immunovant CEO · last filed 2026-07-29
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$79.16M
Companies
3
Total Filings
165
Lifetime Open-Market Net
-$193.75M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ROIV | President & Immunovant CEO | 1,813,063 | $37.37 | $67.75M | -$169.92M | 50 | 2026-07-29 |
| IMVT | Chief Executive Officer | 257,372 | $44.30 | $11.40M | -$461.8K | 4 | 2026-07-06 |
| Roivant Sciences Ltd. (ROIVW) Delisted | President & COO | 611,813 | $2.75 | $1.68M | -$23.37M | 32 | 2023-08-24 |
Recent Filings · Page 15 of 17
165 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-05-02 | ROIV | Notice (144) | −109,074 | -$897.5K | EDGAR |
| 2023-05-01 | ROIV | Notice (144) | −61,155 | -$525.3K | EDGAR |
| 2023-04-28 | ROIV | Notice (144) | −75,823 | -$641.9K | EDGAR |
| 2023-04-28 | Roivant Sciences Ltd. (ROIVW) Delisted | Mixed | — | -$1.04M | EDGAR |
| 2023-04-27 | ROIV | Notice (144) | −73,514 | -$625.9K | EDGAR |
| 2023-04-26 | ROIV | Notice (144) | −72,906 | -$631.7K | EDGAR |
| 2023-04-24 | Roivant Sciences Ltd. (ROIVW) Delisted | Tax (F) | −14,457 | -$127.2K | EDGAR |
| 2023-03-27 | Roivant Sciences Ltd. (ROIVW) Delisted | Other (J) | −14,194 | -$103.6K | EDGAR |
| 2023-02-24 | Roivant Sciences Ltd. (ROIVW) Delisted | Other (J) | −11,953 | -$100.8K | EDGAR |
| 2023-01-26 | Roivant Sciences Ltd. (ROIVW) Delisted | Other (J) | −13,057 | -$111.8K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.